✉ Email this page to a colleague
« Back to Dashboard
▶ Start for $1
Remove trial restrictions
Mitoglitazone is an investigational drug.
There have been 3 clinical trials for Mitoglitazone. The most recent clinical trial was a Phase 2 trial, which was initiated on September 1st 2008.
The most common disease conditions in clinical trials are Diabetes Mellitus, Type 2, Diabetes Mellitus, and Alzheimer Disease. The leading clinical trial sponsors are Metabolic Solutions Development Company and [disabled in preview].
Recent Clinical Trials for Mitoglitazone
|3-month Study of MSDC-0160 Effects on Brain Glucose Utilization, Cognition & Safety in Subjects With Alzheimer's Disease||Metabolic Solutions Development Company||Phase 2|
|Study to Evaluate the Safety, Tolerability and Efficacy of Three Dose Levels of Mitoglitazone in Type 2 Diabetic Patients||Metabolic Solutions Development Company||Phase 2|
|A Placebo Controlled Safety and Efficacy Study of MSDC-0160 in Type 2 Diabetes With Active Comparator||Metabolic Solutions Development Company||Phase 2|